251 related articles for article (PubMed ID: 23205923)
1. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.
Arnold EJ; Childress MO; Fourez LM; Tan KM; Stewart JC; Bonney PL; Knapp DW
J Vet Intern Med; 2011; 25(6):1385-90. PubMed ID: 22092632
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer.
Knapp DW; Glickman NW; Widmer WR; DeNicola DB; Adams LG; Kuczek T; Bonney PL; DeGortari AE; Han C; Glickman LT
Cancer Chemother Pharmacol; 2000; 46(3):221-6. PubMed ID: 11021739
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.
McMillan SK; Boria P; Moore GE; Widmer WR; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2011 Oct; 239(8):1084-9. PubMed ID: 21985349
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder.
Abbo AH; Jones DR; Masters AR; Stewart JC; Fourez L; Knapp DW
J Vet Intern Med; 2010; 24(5):1124-30. PubMed ID: 20695986
[TBL] [Abstract][Full Text] [Related]
8. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.
Schrempp DR; Childress MO; Stewart JC; Leach TN; Tan KM; Abbo AH; de Gortari AE; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2013 Jun; 242(11):1534-8. PubMed ID: 23683018
[TBL] [Abstract][Full Text] [Related]
9. Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
Mohammed SI; Craig BA; Mutsaers AJ; Glickman NW; Snyder PW; deGortari AE; Schlittler DL; Coffman KT; Bonney PL; Knapp DW
Mol Cancer Ther; 2003 Feb; 2(2):183-8. PubMed ID: 12589035
[TBL] [Abstract][Full Text] [Related]
10. Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
Henry CJ; Flesner BK; Bechtel SA; Bryan JN; Tate DJ; Selting KA; Lattimer JC; Bryan ME; Grubb L; Hausheer F
J Vet Intern Med; 2018 Jan; 32(1):370-376. PubMed ID: 29080252
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
Autefage A; Palissier FM; Asimus E; Pepin-Richard C
Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the analgesic efficacy of perioperative firocoxib and tramadol administration in dogs undergoing tibial plateau leveling osteotomy.
Davila D; Keeshen TP; Evans RB; Conzemius MG
J Am Vet Med Assoc; 2013 Jul; 243(2):225-31. PubMed ID: 23822079
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
Ryan WG; Moldave K; Carithers D
Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs.
Moore AS; Cardona A; Shapiro W; Madewell BR
J Vet Intern Med; 1990; 4(3):148-52. PubMed ID: 2366224
[TBL] [Abstract][Full Text] [Related]
15. Tolerance of firocoxib in dogs with osteoarthritis during 90 days.
Lecoindre O; Pepin-Richard C
J Vet Pharmacol Ther; 2011 Apr; 34(2):190-2. PubMed ID: 21395612
[No Abstract] [Full Text] [Related]
16. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
[TBL] [Abstract][Full Text] [Related]
18. Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model.
Goodman L; Torres B; Punke J; Reynolds L; Speas A; Ellis A; Budsberg S
J Vet Intern Med; 2009; 23(1):56-62. PubMed ID: 19175721
[TBL] [Abstract][Full Text] [Related]
19. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.
Knapp DW; Ramos-Vara JA; Moore GE; Dhawan D; Bonney PL; Young KE
ILAR J; 2014; 55(1):100-18. PubMed ID: 24936033
[TBL] [Abstract][Full Text] [Related]
20. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
Vinall RL; Kent MS; deVere White RW
Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
